https://www.selleckchem.com/
fecting the nogo pathway. Lead-212 ( Pb, t = 10.6 h) and lead-203 ( Pb, t = 51.9 h) are an element-equivalent, or a matched theranostic radioisotope pair that show great potential for application in targeted radionuclide therapy (TRT) and single-photon emission computed tomography (SPECT), respectively. At TRIUMF we have produced both Pb and Pb using TRIUMF's TR13 (13 MeV) and 500 MeV cyclotrons, and subsequently purified and evaluated both radioisotopes using a series of pyridine-modified DOTA analogues in comparison to the commercially available chelate
Like
Comment
Share
